The University of Warsaw Technology Transfer Office (UOTT) promotes commercialization of research from the University of Warsaw. It manages over 300 patents and facilitates deals between researchers and companies. UOTT has helped launch 7 startup companies based on university technologies in areas like genetic testing, bioremediation, and data analysis. These startups contribute to healthcare, environmental protection, and other fields.

1. TECHNOLOGY TRANSFER AT UNIVERSITY OF WARSAW
UNIVERSITY OF WARSAW TECHNOLOGY TRANSFER OFFICE

2. ● the largest and one of the best
universities in Poland
● wide scope of disciplines
– humanities, social sciences,
natural and pure sciences
– outreaching technical
and medical universities
● recognized by prestigious international
rankings such as the Academic Ranking
of World Universities (ARWU Shanghai
Ranking), the QS Top Universities,
the Times Higher Education World
University Rankings
UNIVERSITY
O F WARSAW

3. The University community consists of:
● 44 600 students, including
more than 32 000 full time students
more than 12 600 part-time students
● more than 3 200 Ph.D. students
● almost 3 900 postgraduate students
● more than 7 100 employees,
including more than 3 600 academic
teachers more than 820 professors.
The University of Warsaw encompasses:
● 20 faculties
● 30 independent teaching and research units.
UNIVERSITY OF WARSAW

4. ● in the vicinity: the Polish Academy
of Sciences institutes (biochemistry,
biophysics, physiology, genetics),
the Medical University of Warsaw
● supra-regional importance
(the project is financed mainly
from the EU structural funds)
INVESTMENTS R&D: CENTRE
OF NEW TECHNOLOGIES
● the campus of mathematical, natural
and experimental sciences: Physics,
Chemistry, Biology, Geology, Mathematics,
and Informatics as well as the cyclotron
in one location
PHYSICS
CENT (CENTRE OF NEW TECHNOLOGIES)
CNBCH (BIOLOGICAL AND CHEMICAL RESEARCH CENTRE)
HEAVY ION LABORATORY
BIOLOGY
GEOLOGY

5. University of Warsaw Technology
Transfer Office (UOTT) was founded
by the University of Warsaw Senate
in 1998. It’s role is to promote better
use of the University’s intellectual
and technical potential in the
national economy, and also
to support all kind of actions devoted
to the implementa- tion of academic
knowledge into the industry and
commercial market.
UNIVERSITY
OF WARSAW
TECHNOLOGY
TRANSFER OFFICE

6. UNIVERSITY
OF WARSAW
TECHNOLOGY
TRANSFER OFFICE
● Promotion of applied R&D projects
● Innovation and patents management
● finding business partners
● Startup creation
● Contracts negotiation

7. COMMERCIALISATION TRIANGLE
AT THE UNIVERSITY OF WARSAW
UNIVERSITY OF WARSAW TECHNOLOGY TRANSFER OFFICE
Coordination of commercialisation,
Technology transfer from initial invention disclosure through to
commercialisation and post – deal support
UNIVERSITY OF WARSAW INCUBATOR
Providing space and services for spin-off
companies’’ development,promotion
of spin-off companies, mentoring
UWRC LTD (LPV)
The company owned entirely by the University of
Warsaw, forming and developing spin-off companies,
providing seed capital, offering specialized IP
STARTUP 1 STARTUP 2 ... STARTUP N

8. S-ARCA
B-ARCA
INVENTION
The invention concerns the
application of mrna in gene
therapy. These solutions can
help in the effective treatment
of many diseases, including
most malignancies. Therapeutic
delivery of synthetic mrna,
trigger production of specific
proteins inside defected cells.

9. S-ARCA B-ARCA INVENTION
SANOFI AND BIONTECH ANNOUNCE CANCER IMMUNOTHERAPY COLLABORATION AND LICENSE AGREEMENT.
Paris, France and Mainz, Germany – November 3, 2015 – Sanofi and BioNTech A.G. announced their enetring into
a multiyear exclusive collaboration and license agreement. This research collaboration between Sanofi and BioNTech
will leverage the scientific expertise of the two organizations to discover and develop up to five cancer
immunotherapies, each consisting of a mixture of synthetic messenger RNAs (mRNAs).
Sanofi and BioNTech have agreed to $60 million in upfront and near-term milestone payments, payable to BioNTech
under the terms of the agreement. Further, BioNTech could receive over $300 million in development, regulatory and
commercial milestones and other payments per product. If commercialized successfully, BioNTech would also be eligible
for tiered royalties on net sales up to double digits. In addition, BioNTech has the option to co-develop and co-commer-
cialise two of the five mRNA therapeutic products with Sanofi in the European Union and the UnitedStates.

10. THE UNIVERSITY OF WARSAW SPIN-OFFS
?

11. ● Warsaw Genomics spin-off is a company established by researchers
at the University of Warsaw and the Medical University of Warsaw
in order to provide genetic services.
● The company offers genetic tests which help determine
the overall risk of cancer by using the most up to date method
– next generation sequencing. The test allows to identify all known
genetic variations associated with present family forms of breast
and ovarian cancer. Simultaneously, a number of genes (e.g. 25
genes in the test on breast and ovarian cancer) can be examined.
● Warsaw Genomics is an interdisciplinary team including
medical doctors, molecular biologists, geneticists,
bioinformaticians and mathematicians.
● Knowing your genetic predisposition, you can take an action to
prevent cancer or lead to an early diagnosis of cancer.
WARSAW GENOMICS LTD

12. ● Research and Development for Life Sciences (RDLS)
is a spin-off company founded by researchers from the
Faculty of Biology, University of warsaw.
● The company mission is to conduct dedicated research
and provide advanced analytical services in environmental
biotechnology. RDLS offers high quality consortia and
complete array of services: from biotechnological concept
to environmental monitoring and screening.
● Scope of services:
– Environmental monitoring (microbiological and
chemical recognition, controlling and screening)
– Toxic heavy metals removal
– Preservation from bio deterioration
– Examination of the input materials for biogas plants
– Molecular research in microorganism biodiversity
– Consulting & expertise sharing.
RDLS LTD

13. The company creates new
technologies on the needs of
environment and ecological
farming, which also includes
the remediation of polluted
water, soil, and waste.
They have developed a bioreme-
diation vaccine which removes
petroleum substances from fields
and lands lying near the oil
refineries, military proving
grounds and training areas or
railway sidings.
BACTrem LTD

14. ● The AmerLab spin-off is a company established by
researchers of the University of Warsaw and the Medical
University of Warsaw in order to provide access to
advanced diagnosis of parasitic infections in human
and animal organisms using the most recent
technologies.
● The company addresses its offer to both individuals
(adults, children and pet owners) as well as companies
whose employees are exposed to parasitic infections
such as veterinarians.
● Up to date this type of offer was not available in private
or public clinics (NZOZ).
AmerLab lTD
Medical
diagnostics
Veterinary
diagnostics

15. ● Spektrino is a spin-off company established
by an interdisciplinary nuclear magnetic
resonance spectroscopy (NMR) team
at the University of Warsaw.
● The company mission is to develop dedicated
methods for rapid recording and analysis of NMR
data as well as mobile applications for remote
monitoring of hardware status.
● The team also offers NMR spectroscopy-
-methodology consultations and creation
of advanced experimental protocols
based on the fast spectroscopy.
SPEKTRINO LTD

16. ● The company has been founded by researchers from
the Faculty of Mathematics, Informatics andMechanics.
● The company’s activity is focused on advanced data
processing acquired from e-services.
The data analysis can provide informations about:
– customers expectations
– strategy planning
– services personalization.
● The company develops the product of recommendation
and prediction which may be used in different aspects
of big data processing.
● The modern infrastructure allows for trivial
implementations of non-trivial solutions
concerning machine learning.
MIM Solutions lTD

17. The company deals with the
satellite crops monitoring.
It gives the ability to track the
history of selected individual
fields, predicts yields and
harvest time.
In the near future such monitoring
will allow automatic alerting
of appropriate services.
GeoPulse lTD

18. UOTT
CURRENTLY
MANAGES
about 300
patents & patent
applications
12 active
deals
30 projects
in pipeline
7 startups

19. PATENTS FILED IN THE POLISH PATENT OFFICE
5
20
25
15
10
0
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015

20. PATENTS APPLICATIONS AT UNIVERSITY OF WARSAW
5
20
25
15
10
Heavy Ion Laboratory
CeNT (Centre of New Technologies
University of Warsaw)
CNBCh (Biological andChemical
Research Centre)
Geology
linguistics
Biology
Chemistry
Physics
Inter-Faculty Studies
in Environmental Protection
0
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
facUlTies

21. TIMELINE OF THE UNIVERSITY
OF WARSAW INVENTIONS
1998 2009 2010 2011 2012 2013 2014 2015 2016
5 spin-off
companies
RDLS – first
spin-off
Know-how
to Agilient
Licence
to BioNTech
IP Rights to Umicore
UOTT established
4 licences,
1 spin-off

22. 150 identified innovative technological projects and services
25 patent applications
26 evaluated projects
27 strategies of commercialisation
4 business plans
5 launched companies
2 granted licences
1 online database of patented technologies, services and labs
developed at the University of Warsaw oferta.uw.edu.pl
UOTT ACHIEVEMENTS IN 2015

23. ● spin-off networking Club
● Innovation and Technology Transfer
Student Association
● student internships
● competition for the BSc, MSc and PhD thesis
with the greatest commercialisation potential
SUPPORTING ACTIONS

24. THANK YOU!
We will be happy to answer your questions,
please contactus.
uott@uott.uw.edu.pl
www.uott.edu.pl
Żwirki i Wigury 93, room no. 3058, 02-089 Warsaw, Poland
phone/fax: +48 22 55 40 730, www.uott.uw.edu.pl
UNIVERSITY OF WARSAW TECHNOLOGY TRANSFER OFFICE